Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA/CMS Collaboration: “Sleeper Group” Goes Public With Call For Real-World Evidence

Executive Summary

US FDA, CMS and NIH are hoping to create a “single front door” for research. Article outlining collaboration on real-world evidence suggests one path forward.

You may also be interested in...

Real World Evidence: ‘Hot Topic’ At US FDA, But Not On Front Burner

Officials are enthusiastic about the possibility of ‘real world evidence’ supporting the regulatory process – but are also eager to tamp down expectations (or fears) that it will make a big difference any time soon.

Drug Pricing: CMS Seeing ‘Too Many Examples’ Of Excessive Increases

Acting Administrator Slavitt says big prescription drug price increases are a widespread practice and controlling drug costs ‘is likely to be a big priority’ for next head of CMS.

Sentinel’s “IMPACT” Beyond Safety: Anti-Coagulant Study Is Early Test

The Sentinel post-marketing surveillance system is up and running. Now, FDA is ready to explore uses beyond safety.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts